Fischer Medical Peer Comparison

Snapshot Summary

Fischer Medical Ventures Ltd. (FISCHER) is significantly underperforming compared to its peers across multiple metrics, indicating broad-based selling pressure in the Chemicals sector. It shows no revenue growth and high PE and PBV ratios, suggesting it is both overvalued and financially weak relative to more profitable competitors.

• FISCHER shows 0% revenue growth YoY and 3-Year, indicating stagnation.
• Highest PE ratio (10,332.68) indicates overvaluation versus peers.
• Lowest ROE (4.60%) and ROA (4.24%) reveal poor profitability.
• Best value pick is Pidilite Industries Ltd. due to strong growth and low PEG ratio.
• Financially weak companies include Godrej Industries with high debt and low margins.

• Pidilite Industries Ltd.: Strong revenue growth (6.12% YoY) and high ROE (22.45%) with low PE (76.64) makes it attractive.
• Solar Industries India Ltd.: High ROE (29.59%) and efficient cash conversion cycle, despite recent revenue decline.
• SRF Ltd.: Consistent profitability with a PE of 60.69 and an EBITDA margin of 23.14%.

Stock	CMP	Market Cap	P/E	ROE (%)	ROCE (%)	Debt/Equity
FISCHER	₹107.07	₹7,629.78Cr	382.98	0.62%	1.13%	0.20
PIDILITIND	₹1,460.50	₹1,48,611.69Cr	66.75	23.21%	31.16%	0.02
SOLARINDS	₹14,161.00	₹1,28,112.65Cr	101.54	29.59%	31.03%	0.33
SRF	₹2,968.10	₹87,981.85Cr	54.39	12.27%	12.83%	0.43
FLUOROCHEM	₹3,728.30	₹40,862.55Cr	65.70	8.31%	10.02%	0.28
GODREJIND	₹1,128.40	₹37,194.85Cr	36.90	20.50%	10.16%	3.73
NAVINFLUOR	₹5,905.50	₹30,238.26Cr	68.09	11.62%	11.76%	0.55

Explore

Watchlists

Command Palette

Fischer Medical Peer Comparison

Snapshot Summary